American International Group’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
BI
ACM
PIM
CS
American International Group's PVLA Position: Q2 2021 in Review
American International Group sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 387 shares — an estimated $79 sold.
American International Group first reported a position in PVLA in Q2 2017 and held it in 16 quarters. The position peaked at $193K in Q3 2018. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.
- American International Group reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
- American International Group sold 387 Palvella Therapeutics shares in Q2 2021, an estimated $79.
- American International Group first reported a position in Palvella Therapeutics in Q2 2017 and held it in 16 quarters.
- American International Group's Palvella Therapeutics position peaked at $193K in Q3 2018.
- 73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.